Anifrolumab for refractory dermatomyositis: Experience from a Spanish cohort. - Álvarez Troncoso J; Sendagorta Cudos E; Fiz Benito E; Calero Paniagua I; Robles Marhuenda Á (European Journal Of Internal Medicine, 2025)